Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

Clinical Oncology Society of Australia position statement on cancer survivorship care.

Vardy JL, Chan RJ, Koczwara B, Lisy K, Cohn RJ, Joske D, Dhillon HM, Jefford M.

Aust J Gen Pract. 2019 Dec;48(12):833-836. doi: 10.31128/AJGP-07-19-4999.

PMID:
31774985
2.

Building a novel occupational rehabilitation program to support cancer survivors to return to health, wellness, and work in Australia.

Sheppard DM, Frost D, Jefford M, O'Connor M, Halkett G.

J Cancer Surviv. 2019 Nov 11. doi: 10.1007/s11764-019-00824-3. [Epub ahead of print]

PMID:
31713100
3.

Clinical placement program in cancer survivorship for primary care providers 2017-2019.

Piper A, Leon L, Kelly H, Bailey A, Wiley G, Lisy K, Simkiss L, Jefford M.

J Cancer Surviv. 2019 Oct 24. doi: 10.1007/s11764-019-00817-2. [Epub ahead of print]

PMID:
31650472
4.

Return to Work in Survivors of Human Papillomavirus-Associated Oropharyngeal Cancer: An Australian Experience.

Morales CZ, McDowell L, Lisy K, Piper A, Jefford M.

Int J Radiat Oncol Biol Phys. 2019 Sep 12. pii: S0360-3016(19)33751-4. doi: 10.1016/j.ijrobp.2019.09.001. [Epub ahead of print]

PMID:
31521718
5.

Tools to facilitate communication during physician-patient consultations in cancer care: An overview of systematic reviews.

Licqurish SM, Cook OY, Pattuwage LP, Saunders C, Jefford M, Koczwara B, Johnson CE, Emery JD.

CA Cancer J Clin. 2019 Nov;69(6):497-520. doi: 10.3322/caac.21573. Epub 2019 Jul 24. Review.

6.

The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment.

Wong Doo N, White VM, Martin K, Bassett JK, Prince HM, Harrison SJ, Jefford M, Winship I, Millar JL, Milne RL, Seymour JF, Giles GG.

Cancers (Basel). 2019 Jul 2;11(7). pii: E928. doi: 10.3390/cancers11070928.

7.

Re: Developing a Quality of Cancer Survivorship Care Framework: Implications for Clinical Care, Research and Policy.

Jefford M.

J Natl Cancer Inst. 2019 Jun 24. pii: djz128. doi: 10.1093/jnci/djz128. [Epub ahead of print] No abstract available.

PMID:
31233142
8.

Identifying the most prevalent unmet needs of cancer survivors in Australia: A systematic review.

Lisy K, Langdon L, Piper A, Jefford M.

Asia Pac J Clin Oncol. 2019 Oct;15(5):e68-e78. doi: 10.1111/ajco.13176. Epub 2019 Jun 18.

PMID:
31215167
9.

Have centralised ethics and governance applications improved the time-variable, and approval process to conduct research in Victorian hospitals?

Baguley BJ, Jefford M, Aly A, Cashin P, White V.

Intern Med J. 2019 Jun;49(6):807-808. doi: 10.1111/imj.14276. No abstract available.

PMID:
31185521
10.

The survivorship experience for patients with metastatic melanoma on immune checkpoint and BRAF-MEK inhibitors.

Lai-Kwon J, Khoo C, Lo S, Milne D, Mohamed M, Raleigh J, Smith K, Lisy K, Sandhu S, Jefford M.

J Cancer Surviv. 2019 Aug;13(4):503-511. doi: 10.1007/s11764-019-00770-0. Epub 2019 Jun 4.

PMID:
31165342
11.

Building Personalized Cancer Follow-up Care Pathways in the United States: Lessons Learned From Implementation in England, Northern Ireland, and Australia.

Alfano CM, Jefford M, Maher J, Birken SA, Mayer DK.

Am Soc Clin Oncol Educ Book. 2019 Jan;39:625-639. doi: 10.1200/EDBK_238267. Epub 2019 May 17. Review.

12.

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience.

Sahu A, Jefford M, Lai-Kwon J, Thai A, Hicks RJ, Michael M.

J Oncol. 2019 Feb 20;2019:9032753. doi: 10.1155/2019/9032753. eCollection 2019.

13.

Assessing the cost-effectiveness of RT Prepare: A radiation therapist-delivered intervention for reducing psychological distress prior to radiotherapy.

Youens D, Halkett G, Wright C, O'Connor M, Schofield P, Jefford M, Aranda S, Kane R, Moorin R; RT Prepare project team.

Psychooncology. 2019 May;28(5):1110-1118. doi: 10.1002/pon.5065. Epub 2019 Apr 10.

PMID:
30884030
14.

A longitudinal study of four unique trajectories of psychological distress in cancer survivors after completing potentially curative treatment.

Lotfi-Jam K, Gough K, Schofield P, Aranda S, Jefford M.

Acta Oncol. 2019 May;58(5):782-789. doi: 10.1080/0284186X.2018.1562209. Epub 2019 Jan 30.

PMID:
30698063
15.

Patient-reported outcomes of sexual and gender minority cancer survivors in Australia.

Lisy K, Ward A, Schofield P, Hulbert-Williams N, Bishop J, Jefford M.

Psychooncology. 2019 Feb;28(2):442-444. doi: 10.1002/pon.4956. Epub 2018 Dec 18. No abstract available.

PMID:
30511405
16.

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study.

Shapiro JD, Thavaneswaran S, Underhill CR, Robledo KP, Karapetis CS, Day FL, Nott LM, Jefford M, Chantrill LA, Pavlakis N, Tebbutt NC, Price TJ, Khasraw M, Van Hazel GA, Waring PM, Tejpar S, Simes J, Gebski VJ, Desai J, Segelov E.

Clin Colorectal Cancer. 2018 Dec;17(4):313-319. doi: 10.1016/j.clcc.2018.06.002. Epub 2018 Jun 8.

PMID:
30463680
17.

Recommendations for clinical translation of nanoparticle-enhanced radiotherapy.

Ricketts K, Ahmad R, Beaton L, Cousins B, Critchley K, Davies M, Evans S, Fenuyi I, Gavriilidis A, Harmer QJ, Jayne D, Jefford M, Loizidou M, Macrobert A, Moorcroft S, Naasani I, Ong ZY, Prise KM, Rannard S, Richards T, Schettino G, Sharma RA, Tillement O, Wakefield G, Williams NR, Yaghini E, Royle G.

Br J Radiol. 2018 Dec;91(1092):20180325. doi: 10.1259/bjr.20180325. Epub 2018 Sep 17.

18.

Feasibility of 5-fluorouracil pharmacokinetic monitoring using the My-5FU PCM™ system in a quaternary oncology centre.

Moloney M, Faulkner D, Link E, Rischin D, Solomon B, Lim AM, Zalcberg JR, Jefford M, Michael M.

Cancer Chemother Pharmacol. 2018 Nov;82(5):865-876. doi: 10.1007/s00280-018-3679-4. Epub 2018 Sep 3.

PMID:
30178115
19.

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.

Batten LM, Bhattacharya IS, Moretti L, Haviland JS, Emson MA, Miller SE, Jefford M, MacKenzie M, Wilcox M, Hyslop M, Todd R, Snowdon CF, Bliss JM.

Res Involv Engagem. 2018 Jul 16;4:22. doi: 10.1186/s40900-018-0108-0. eCollection 2018.

20.

Culturally and linguistically diverse oncology patients' perspectives of consultation audio-recordings and question prompt lists.

Hyatt A, Lipson-Smith R, Gough K, Butow P, Jefford M, Hack TF, Hale S, Zucchi E, White S, Ozolins U, Schofield P.

Psychooncology. 2018 Sep;27(9):2180-2188. doi: 10.1002/pon.4789. Epub 2018 Jul 12.

PMID:
29893041
21.

RT Prepare: a radiation therapist-delivered intervention reduces psychological distress in women with breast cancer referred for radiotherapy.

Halkett G, O'Connor M, Jefford M, Aranda S, Merchant S, Spry N, Kane R, Shaw T, Youens D, Moorin R, Schofield P; RT Prepare project team.

Br J Cancer. 2018 Jun;118(12):1549-1558. doi: 10.1038/s41416-018-0112-z. Epub 2018 Jun 1.

22.

Experiences and unmet needs of lesbian, gay, and bisexual people with cancer care: A systematic review and meta-synthesis.

Lisy K, Peters MDJ, Schofield P, Jefford M.

Psychooncology. 2018 Jun;27(6):1480-1489. doi: 10.1002/pon.4674. Epub 2018 Mar 15.

PMID:
29462496
23.

Developing Written Information for Cancer Survivors from Culturally and Linguistically Diverse Backgrounds: Lessons Learnt.

Wiley G, Piper A, Phyllis Butow AM, Schofield P, Douglas F, Roy J, Nolte L, Jefford M.

Asia Pac J Oncol Nurs. 2018 Jan-Mar;5(1):121-126. doi: 10.4103/apjon.apjon_63_17.

24.

Translating Research into Community Practice: The Healthy Living after Cancer Partnership Project.

Eakin E, Hayes S, Reeves M, Goode A, Vardy J, Boyle F, Haas M, Hiller J, Mishra G, Jefford M, Koczwara B, Saunders C, Chapman K, Boltong A, Lane K, Baldwin P, Robertson A, Millar L, McKiernan S, Demark-Wahnefried W, Courneya K, Robson E.

Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S31. doi: 10.1002/oby.22015. No abstract available.

25.

SCORE: Shared care of Colorectal cancer survivors: protocol for a randomised controlled trial.

Jefford M, Emery J, Grunfeld E, Martin A, Rodger P, Murray AM, De Abreu Lourenco R, Heriot A, Phipps-Nelson J, Guccione L, King D, Lisy K, Tebbutt N, Burgess A, Faragher I, Woods R, Schofield P.

Trials. 2017 Oct 30;18(1):506. doi: 10.1186/s13063-017-2245-4.

26.

Provider Roles in Survivorship Care: Moving Beyond Surveys of Patient Preference.

Lisy K, Emery JD, Jefford M.

J Clin Oncol. 2017 Dec 1;35(34):3890. doi: 10.1200/JCO.2017.75.7187. Epub 2017 Oct 12. No abstract available.

PMID:
29023216
27.

Measuring recall of medical information in non-English-speaking people with cancer: A methodology.

Lipson-Smith R, Hyatt A, Murray A, Butow P, Hack TF, Jefford M, Ozolins U, Hale S, Schofield P.

Health Expect. 2018 Feb;21(1):288-299. doi: 10.1111/hex.12614. Epub 2017 Sep 22.

28.

A rapid review of needs assessment tools for post-treatment cancer survivors.

Jiao M, Hall AE, Nolte L, Piper A, Lisy K, Jefford M.

Eur J Cancer Care (Engl). 2018 Mar;27(2):e12764. doi: 10.1111/ecc.12764. Epub 2017 Sep 18. Review.

PMID:
28921739
29.

A Randomized Controlled Trial of an Additional Funding Intervention to Improve Clinical Trial Enrollment.

Parker C, Snyder R, Jefford M, Dilts D, Wolfe R, Millar J.

J Natl Compr Canc Netw. 2017 Sep;15(9):1104-1110. doi: 10.6004/jnccn.2017.0150.

PMID:
28874595
30.

Distress and unmet needs during treatment and quality of life in early cancer survivorship: A longitudinal study of haematological cancer patients.

Oberoi DV, White VM, Seymour JF, Prince HM, Harrison S, Jefford M, Winship I, Hill DJ, Bolton D, Millar J, Wong Doo N, Kay A, Giles G.

Eur J Haematol. 2017 Nov;99(5):423-430. doi: 10.1111/ejh.12941. Epub 2017 Oct 9.

PMID:
28833529
31.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

32.

The influence of unmet supportive care needs on anxiety and depression during cancer treatment and beyond: a longitudinal study of survivors of haematological cancers.

Oberoi D, White VM, Seymour JF, Miles Prince H, Harrison S, Jefford M, Winship I, Hill D, Bolton D, Kay A, Millar J, Doo NW, Giles G.

Support Care Cancer. 2017 Nov;25(11):3447-3456. doi: 10.1007/s00520-017-3766-9. Epub 2017 Jun 30.

PMID:
28667564
33.

Transforming Cancer Survivorship Care: An Australian Experience.

Kinnane NA, Piper A, Wiley G, Nolte L, Evans J, Jefford M.

Asia Pac J Oncol Nurs. 2017 Apr-Jun;4(2):91-94. doi: 10.4103/2347-5625.204498. No abstract available.

34.

Trends in the surgical management of stage 1 renal cell carcinoma: findings from a population-based study.

White V, Marco DJT, Bolton D, Davis ID, Jefford M, Hill D, Prince HM, Millar JL, Winship IM, Coory M, Giles GG.

BJU Int. 2017 Nov;120 Suppl 3:6-14. doi: 10.1111/bju.13889. Epub 2017 Jun 9.

35.

Patient-reported outcomes in cancer survivors: a population-wide cross-sectional study.

Jefford M, Ward AC, Lisy K, Lacey K, Emery JD, Glaser AW, Cross H, Krishnasamy M, McLachlan SA, Bishop J.

Support Care Cancer. 2017 Oct;25(10):3171-3179. doi: 10.1007/s00520-017-3725-5. Epub 2017 Apr 22.

PMID:
28434095
36.

FOLFOX and intensified split-course chemoradiation as initial treatment for rectal cancer with synchronous metastases.

Bird T, Michael M, Bressel M, Chu J, Chander S, Cooray P, McKendrick J, Jefford M, Heriot A, Steel M, Leong T, Ngan S.

Acta Oncol. 2017 May;56(5):646-652. doi: 10.1080/0284186X.2017.1296584. Epub 2017 Mar 16.

PMID:
28301974
37.

Communication challenges experienced by migrants with cancer: A comparison of migrant and English-speaking Australian-born cancer patients.

Hyatt A, Lipson-Smith R, Schofield P, Gough K, Sze M, Aldridge L, Goldstein D, Jefford M, Bell ML, Butow P.

Health Expect. 2017 Oct;20(5):886-895. doi: 10.1111/hex.12529. Epub 2017 Mar 5.

38.

Parallel multicentre randomised trial of a clinical trial question prompt list in patients considering participation in phase 3 cancer treatment trials.

Tattersall MH, Jefford M, Martin A, Olver I, Thompson JF, Brown RF, Butow PN.

BMJ Open. 2017 Mar 1;7(3):e012666. doi: 10.1136/bmjopen-2016-012666.

39.

The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivorship period.

Oberoi D, White V, Seymour J, Prince HM, Harrison S, Jefford M, Winship I, Hill D, Bolton D, Kay A, Millar J, Doo NW, Giles G.

J Cancer Surviv. 2017 Jun;11(3):329-338. doi: 10.1007/s11764-016-0591-y. Epub 2017 Jan 31.

PMID:
28144891
40.

Barriers and facilitators to the implementation of audio-recordings and question prompt lists in cancer care consultations: A qualitative study.

Moloczij N, Krishnasamy M, Butow P, Hack TF, Stafford L, Jefford M, Schofield P.

Patient Educ Couns. 2017 Jun;100(6):1083-1091. doi: 10.1016/j.pec.2017.01.005. Epub 2017 Jan 16.

41.

How will cancer survivors use survivorship care plans?

Kinnane NA, Piper AJ, Jefford M.

Acta Oncol. 2017 Feb;56(2):183-189. doi: 10.1080/0284186X.2016.1266082. Epub 2016 Dec 31.

PMID:
28040988
42.

The Impact of Survivorship Care Planning on Patients, General Practitioners, and Hospital-Based Staff.

Nolte L, Kinnane N, Lai-Kwon J, Gates P, Shilkin P, Jefford M.

Cancer Nurs. 2016 Nov/Dec;39(6):E26-E35.

PMID:
26720214
43.

Communication skills training for radiation therapists: preparing patients for radiation therapy.

Halkett G, O'Connor M, Aranda S, Jefford M, Merchant S, York D, Miller L, Schofield P.

J Med Radiat Sci. 2016 Dec;63(4):232-241. doi: 10.1002/jmrs.171. Epub 2016 Apr 21.

44.

Development and evaluation of an online educational resource about cancer survivorship for cancer nurses: a mixed-methods sequential study.

Shaw T, Yates P, Moore B, Ash K, Nolte L, Krishnasamy M, Nicholson J, Rynderman M, Avery J, Jefford M.

Eur J Cancer Care (Engl). 2017 Jul;26(4). doi: 10.1111/ecc.12576. Epub 2016 Oct 10.

PMID:
27726221
45.

A clinical placement program for primary care professionals at a comprehensive cancer centre.

Evans J, Nolte L, Piper A, Simkiss L, Whitfield K, Jefford M.

Aust Fam Physician. 2016 Aug;45(8):606-10.

46.

ProCare Trial: a phase II randomized controlled trial of shared care for follow-up of men with prostate cancer.

Emery JD, Jefford M, King M, Hayne D, Martin A, Doorey J, Hyatt A, Habgood E, Lim T, Hawks C, Pirotta M, Trevena L, Schofield P.

BJU Int. 2017 Mar;119(3):381-389. doi: 10.1111/bju.13593. Epub 2016 Aug 29.

47.

A Randomized Controlled Trial of a Nurse-Led Supportive Care Package (SurvivorCare) for Survivors of Colorectal Cancer.

Jefford M, Gough K, Drosdowsky A, Russell L, Aranda S, Butow P, Phipps-Nelson J, Young J, Krishnasamy M, Ugalde A, King D, Strickland A, Franco M, Blum R, Johnson C, Ganju V, Shapiro J, Chong G, Charlton J, Haydon A, Schofield P.

Oncologist. 2016 Aug;21(8):1014-23. doi: 10.1634/theoncologist.2015-0533. Epub 2016 Jun 15.

48.

Are audio recordings the answer? - a pilot study of a communication intervention for non-English speaking patients with cancer.

Lipson-Smith R, Hyatt A, Butow P, Hack TF, Jefford M, Hale S, Hocking A, Sirianni M, Ozolins U, Yiu D, Schofield P.

Psychooncology. 2016 Oct;25(10):1237-1240. doi: 10.1002/pon.4193. Epub 2016 Jul 8. No abstract available.

PMID:
27291636
49.

ICECREAM: randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours.

Segelov E, Waring P, Desai J, Wilson K, Gebski V, Thavaneswaran S, Elez E, Underhill C, Pavlakis N, Chantrill L, Nott L, Jefford M, Khasraw M, Day F, Wasan H, Ciardiello F, Karapetis C, Joubert W, van Hazel G, Haydon A, Price T, Tejpar S, Tebbutt N, Shapiro J.

BMC Cancer. 2016 May 31;16:339. doi: 10.1186/s12885-016-2389-8.

50.

Caregivers' information needs and their 'experiences of care' during treatment are associated with elevated anxiety and depression: a cross-sectional study of the caregivers of renal cancer survivors.

Oberoi DV, White V, Jefford M, Giles GG, Bolton D, Davis I, Winship I, Prince HM, Millar J, Harrison S, Kay A, Hill D.

Support Care Cancer. 2016 Oct;24(10):4177-86. doi: 10.1007/s00520-016-3245-8. Epub 2016 May 5.

PMID:
27146491

Supplemental Content

Loading ...
Support Center